ArticleClinical and translational allergy2022

Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria.

Ana Giménez-Arnau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.